ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,836.22
0.16%
US Tech 100
20,384.40
0.80%
Dow Jones
42,297.12
0.86%
Brent Oil
80.405
0.16%
Bitcoin
97,162.02
2.80%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Elixirr International Plc (ELIX) Quote

Elixirr International Plc

Elixirr International Plc (ELIX)

LSE
700.00
2.00
( 0.29% )
Updated: 03:00:26
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
700.00
Bid
690.00
Ask
710.00
Volume
1,017
700.00 Day's Range 710.00
525.00 52 Week Range 805.00
Market Cap
330.91M
Previous Close
698.00
Open
700.00
Last Trade
431
@
695.5
(O)
Last Trade Time
04:19:35
Financial Volume
7,221p
VWAP
710.00
Average Volume (3m)
182,340
Shares Outstanding
47,272,811
Dividend Yield
2.26%
PE Ratio
19.20
Earnings Per Share (EPS)
0.36
Revenue
85.89M
Net Profit
17.24M

About Elixirr International Plc

Sector
Management Consulting Svcs
Industry
Management Consulting Svcs
Website
www.elixirr.com
Headquarters
London, Gbr
Founded
-
Elixirr International Plc is listed in the Management Consulting Svcs sector of the London Stock Exchange with ticker ELIX. The last closing price for Elixirr was 698p. Over the last year, Elixirr shares have traded in a share price range of 525.00p to 805.00p.

Elixirr currently has 47,272,811 shares outstanding. The market capitalization of Elixirr is £329.96 million. Elixirr has a price to earnings ratio (PE ratio) of 19.20.

Ask ADVFN Intelligence (AI)

ELIX Latest News

More News

Elixirr International PLC Board Appointment

Elixirr International PLC 13 January 2025     ELIXIRR INTERNATIONAL PLC ("Elixirr", the "Company" or "Group") Board Appointment Further to its announcement on 10 December 2024 regarding...

January 13 2025
RNS Regulatory News

Elixirr International PLC Appointment of Joint Broker

Elixirr International PLC 06 January 2025   ELIXIRR INTERNATIONAL PLC ("Elixirr", the "Company" or "Group") Appointment of Joint Corporate Broker Elixirr International plc (AIM:ELIX), an...

January 06 2025
RNS Regulatory News

Elixirr International PLC Director/PDMR Shareholding

Elixirr International PLC 20 December 2024     ELIXIRR INTERNATIONAL PLC ("Elixirr", the "Company" or "Group") Director/PDMR Shareholding Elixirr International plc (AIM:ELIX), an established...

December 20 2024
RNS Regulatory News

Elixirr International PLC Interim Dividend

Elixirr International PLC 20 December 2024   20 December 2024   ELIXIRR INTERNATIONAL PLC   Interim Dividend for the Year Ending 31 December 2024 The Board of Elixirr International plc (AIM:...

December 20 2024
RNS Regulatory News

Elixirr names new deputy CEO and CFO in executive shuffle

Elixirr International PLC on Tuesday said its current chief financial officer will become deputy chief executive offi ...

December 10 2024
Alliance News

Elixirr International PLC Board Changes

Elixirr International PLC 10 December 2024     ELIXIRR INTERNATIONAL PLC ("Elixirr", the "Company" or "Group") Board Changes Elixirr International plc (AIM:ELIX), an established, global...

December 10 2024
RNS Regulatory News

Elixirr International PLC Change of Adviser

Elixirr International PLC 25 November 2024     ELIXIRR INTERNATIONAL PLC ("Elixirr", the "Company" or "Group") Change of Adviser Elixirr International plc (AIM:ELIX), an established, global...

November 25 2024
RNS Regulatory News

Elixirr International PLC PDMR Dealings

Elixirr International PLC 31 October 2024     ELIXIRR INTERNATIONAL PLC ("Elixirr", the "Company" or "Group") PDMR Shareholdings Elixirr International plc (AIM:ELIX), an established, global...

October 31 2024
RNS Regulatory News

IN BRIEF: Elixirr directors and others sell GBP25 million in shares

onal PLC - London-based business consultancy - A group of selling shareholders, including company directors, bank a to ...

October 25 2024
Alliance News

Elixirr International PLC Director/PDMR Shareholding

Elixirr International PLC 25 October 2024     ELIXIRR INTERNATIONAL PLC ("Elixirr", the "Company" or "Group") PDMR Shareholdings Elixirr International plc (AIM:ELIX), an established, global...

October 25 2024
RNS Regulatory News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-20-2.7777777777872072069532318699.45902258DE
4-65-8.4967320261476576569516331710.7693488DE
12-15-2.0979020979715805590182340675.81240641DE
2616029.6296296296540805540100252665.74892456DE
52102.517.1548117155597.580552564412647.2841886DE
156-45-6.0402684563874580541039348609.83753328DE
260478215.31531531522280519041013536.55157755DE

ELIX - Frequently Asked Questions (FAQ)

What is the current Elixirr share price?
The current share price of Elixirr is 700.00p
How many Elixirr shares are in issue?
Elixirr has 47,272,811 shares in issue
What is the market cap of Elixirr?
The market capitalisation of Elixirr is GBP 329.96M
What is the 1 year trading range for Elixirr share price?
Elixirr has traded in the range of 525.00p to 805.00p during the past year
What is the PE ratio of Elixirr?
The price to earnings ratio of Elixirr is 19.2
What is the cash to sales ratio of Elixirr?
The cash to sales ratio of Elixirr is 3.85
What is the reporting currency for Elixirr?
Elixirr reports financial results in GBP
What is the latest annual turnover for Elixirr?
The latest annual turnover of Elixirr is GBP 85.89M
What is the latest annual profit for Elixirr?
The latest annual profit of Elixirr is GBP 17.24M
What is the registered address of Elixirr?
The registered address for Elixirr is 12 HELMET ROW, LONDON, EC1V 3QJ
What is the Elixirr website address?
The website address for Elixirr is www.elixirr.com
Which industry sector does Elixirr operate in?
Elixirr operates in the MANAGEMENT CONSULTING SVCS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TRLSTrellus Health Plc
2.35p
(291.67%)
54.67M
SMLStrategic Minerals Plc
0.235p
(19.90%)
1.28M
MHCMyhealthchecked Plc
15.25p
(17.31%)
140.33k
MILAMila Resources Plc
0.40p
(14.29%)
1.58M
ALKAlkemy Capital Investments Plc
148.50p
(14.23%)
58.87k
THRUThruvision Group Plc
4.50p
(-30.77%)
117.26k
GSTGstechnologies Ltd
2.175p
(-20.62%)
87.57M
PEBPebble Beach Systems Group Plc
7.75p
(-20.51%)
322.32k
SYMESupply@me Capital Plc
0.003p
(-18.92%)
17.12M
BLUBlue Star Capital Plc
6.75p
(-18.18%)
648.04k
TRPTower Resources Plc
0.0345p
(-2.82%)
200.71M
GSTGstechnologies Ltd
2.175p
(-20.62%)
87.57M
PREMPremier African Minerals Limited
0.0395p
(1.28%)
68.28M
TRLSTrellus Health Plc
2.35p
(291.67%)
54.67M
SNDASunda Energy Plc
0.0625p
(-6.02%)
46.96M

Discussion

View Full Feed
Golden Cross Golden Cross 8 minutes ago
$ILLR Many Reasons To Like Triller Now!

~ Launch of Triller 5.0 App.
~ New Streaming Acquisition News Soon
~ Multiple Revenue Streams.
~ New CEO of Triller App is former TikTok executive Sean Kim.
~ TikTok US ban starts 1-19, 2025. Federal court just upheld
ILLR
Golden Cross Golden Cross 9 minutes ago
💎 $ILLR Many Reasons To Like Triller Now⬇️

~ Launch of Triller 5.0 App.
~ New Streaming Acquisition News Soon
~ Multiple Revenue Streams.
~ New CEO of Triller App is former TikTok executive Sean Kim.
~ TikTok US ban starts 1-19, 2025. Federal cour
ILLR
kspar1 kspar1 11 minutes ago
Wow! I had no idea the JPM conference in San Francisco is as energetic as this link reads, including the partnership announcements. Will be fun to see how Anavex is positioned. The conference supposed to generate $92M for the city.
https://www.fiercebiotech.com/biotech/jpm25-day-1-fierce-bio
JPM
Frankestin Frankestin 11 minutes ago
Truist Securities raises PT to $180 from $150 😮
The next two weeks will be eventful
AXS-07, a candidate for the acute treatment of migraines, with expectations for regulatory approval
NDA for AXS-14 for fibromyalgia... maybe yes or maybe no
AXSM
Number sleven Number sleven 15 minutes ago
https://www.courtlistener.com/docket/59859757/dr-reddys-laboratories-inc-v-amarin-pharma-inc/?page=2
Sleven,
AMRN
price_and_volume price_and_volume 19 minutes ago
"Right news" gonna get $175-350MM market cap? LOL!

Omg what a maroon.
VXIT
The Danish Dude The Danish Dude 19 minutes ago
Nice and interesting analysis, but completely irrelevant >!

I fed ChatGPT the following five comments regarding this analysis and it disagrees with you.

I saw these comments regarding how MHRA approves or rejects medecines at mhra meetings

1
NWBO
lakers17 lakers17 21 minutes ago
MTC back to $96,000 after hitting $89, 200s yesterday. Cryptos I added to in the last couple of days were BOBO, PAI, OTTO and CLUSTR. RING AI looking better. Boom or bust for me.
MTC
Golden Cross Golden Cross 24 minutes ago
Loading Zone Here! $ASII
ASII
Hi_Lo Hi_Lo 33 minutes ago
Where is the CSE press release filing?

TWOH has been halted for more than a week now and the CSE press release is still missing.

Could the run up before the halt be the problem?

Could some people have been tipped off before the run up?

Coul
TWOH
SkeBallLarry SkeBallLarry 40 minutes ago
https://scontent-mia3-1.xx.fbcdn.net/v/t39.30808-6/473323273_992397186268896_4170433101098362110_n.jpg?_nc_cat=100&ccb=1-7&_nc_sid=833d8c&_nc_ohc=UebR9WKXEXsQ7kNvgELlMGV&_nc_zt=23&_nc_ht=scontent-mia3-1.xx&_nc_gid=AvB9U-Cb1bfWGguzkXzMzar&oh=00_AYDqG-tA0ScuUz90hSjz11X1LQL5aezyuhOfdBXmp9pGuQ&oe=678C04
Dodger1 Dodger1 42 minutes ago
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175652942 I Miss Real
AABB
jondoeuk jondoeuk 45 minutes ago
NEUK201-00* is being tested in advanced/metastatic solid tumours at a single site.

https://i.postimg.cc/fyWcxcwj/download.png

* It could be an iNK with just a high-affinity non-cleavable CD16(a) receptor, but this comes from a Chinese site that has under
HPQ
marcis marcis 46 minutes ago
I was just thinking the same thing

Go bother those serial OTC stock hijackers
( we know them all well ) that’s been doing LOI mergers, asset ( no asset ) transfers for years with never a real company.
( not you Prophet, to the shills )
Save those investors
RDAR
No-Quarter No-Quarter 47 minutes ago
Good to know, thx!
LetGoodTimesRoll LetGoodTimesRoll 47 minutes ago
The criminality surrounding BLUE Sheets data is rampant...

https://www.sec.gov/newsroom/press-releases/2025-5?utm_medium=email&utm_source=govdelivery
FOXO
Seminole Red Seminole Red 48 minutes ago
https://scontent-mia3-2.xx.fbcdn.net/v/t39.30808-6/472742874_1004087688423643_1614366062036311373_n.jpg?_nc_cat=1&ccb=1-7&_nc_sid=833d8c&_nc_ohc=nfcGrMsEIhAQ7kNvgF3nw1U&_nc_zt=23&_nc_ht=scontent-mia3-2.xx&_nc_gid=AZgGdnGS_3zIT8EnJ2PY5KX&oh=00_AYA_PYWQyRmy2OxdvryhKxL8uHQSf69FZtEDZ_CZJ06VFQ&oe=678BF3D
Bubae Bubae 48 minutes ago
New shares flying everywhere from the looks of the filings. Form 144 filed on January 10th by Atlas Merchant Capital LLC intent to sell 1,241,144 shares. approximate date of sale listed as 01/10/2025. Robert E. Diamond, Triller Chairman of the Board, Chief Executive Officer of Atlas Merchant Capita
ILLR
meshcan meshcan 50 minutes ago
Yes, hence I was saying the really numbers will be in a couple quarters from now, August CC will be two full quarters that we have Vyvanse sell numbers.

CC: NASDAC2020
ELTP
PlaneReflection PlaneReflection 50 minutes ago
Remember when you said it won't pass $2 again?

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174119656

Please say it won't pass $10 again, $30 again and it'll never be over $200. Thanks.
FNMA
eagle8 eagle8 52 minutes ago
ATLnsider
@ATLnsider
Global future for $NWBO #DCVax dendritic cell vaccine platform could be unlimited if efficacy is proven to be tumor & tissue agnostic for all solid tumor cancers & when combined with checkpoint inhibitors can also effectively treat all blood or liquid cancers. NWBi
NWBO
PROPHET-of-PROFITS PROPHET-of-PROFITS 52 minutes ago
The old CEO of rdar has a new stock already to transfer all of his garbage into. But you watch the bearish comments here Will Never follow Jacob to that new stock where efforts should be made to protect people from making a bad investment. Negative bearish comments and all the effort to create them
RDAR
Pickme2 Pickme2 53 minutes ago
The only proof here is you constantly saying this is the best setup and challenge...yet it keeps going down down from .31 cents to .03 ...now .05  and despite the company saying this S-1 offering filled with the SEC will cause dilution and shareholders will have a hard time selling...you continue to
ATMH

Your Recent History

LSE
ELIX
Elixirr
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads